Access to begin phase II trial of OraRinse for treatment and prevention of mucositis Jan. 31, 2000 No Comments
Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer Jan. 28, 2000 No Comments
Genotropin delivery device now available for long-term replacement therapy in GHD Jan. 24, 2000 No Comments
FDA approves two-dose regimen of Merck & Co.'s Recombivax HB for adolescent use Jan. 21, 2000 No Comments